AUCENTRA Therapeutics

Developing breakthrough classes of drugs to address unmet medical need for some of the most severe cancers

AUCENTRA’s deep pipeline of proprietary anti-cancer drugs, developed in partnership with the University of South Australia, includes candidates for the treatment of leukemia, ovarian cancer, glioblastoma, colorectal cancer, breast cancer, prostate cancer, liver cancer and lung cancer.

AUCENTRA develops breakthrough classes of drugs to address unmet medical need for some of the most severe cancers. The company’s novel compounds are more targeted and efficacious than current therapeutics, with less side effects.

linkedin.com

AUCENTRA Therapeutics